| Name | Title | Contact Details |
|---|---|---|
Peter Vladimirov |
Chief Technology Officer | Profile |
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Whisper Hearing Center is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
All Stat Home Health provides a full range of In-Home and Private Duty Home Health Care, catering specifically to the needs of the patient and family. We supply nursing personnel to Hospitals, Nursing Centers, Doctor's Offices and for private duty
Compumed Inc is a Meeteetse, WY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dac Medical is a Southlake, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.